黄泽彬博士 医药高级投资分析师

黄泽彬博士专注于医疗健康和生物科技产业的分析研究和投资,擅长精准医疗、基因治疗、细胞疗法、体外诊断、基因工程和生物制药领域。 加入蓝海资本之前,黄博士在澳门大学健康科学学院从事了四年生物医药研发工作,重点研究癌症等重大疾病的发病机制,开发药物新靶点,以及研发精准医疗和基因治疗等新技术用于临床治疗和产业化,并在《Oncogene》等国际权威学术期刊上发表了多篇研究论文。 黄博士毕业于清华大学医学部北京协和医学院,获博士学位,师从王琳芳院士。

Zebin Huang, Ph.D
Senior Healthcare Analyst

Dr. Zebin Huang focuses on the investment fields of precision medicine, gene therapy, cell therapy, in vitro diagnostics, genetic engineering and biopharmacy. Prior to joining BOCG, Dr. Huang worked as a research fellow at the Faculty of Health Sciences at University of Macau for 4 years, focusing on exploring pathogenesis on major diseases such as cancer, new drug targets, precision medicine and gene therapy. He had published research papers in international authoritative academic journals such as Oncogene. Dr. Huang graduated with a Ph.D. degree from Peking Union Medical College, Tsinghua University, where he studied under Academician Linfang Wang.